8 news items
Why Is Jazz Pharmaceuticals Stock Trading Lower On Thursday?
JAZZ
20 Jun 24
) released topline results from the Phase 2b trial evaluating the efficacy and safety of suvecaltamide (JZP385), an investigational, highly
Jazz Pharmaceuticals Provides Update on Phase 2b Trial of Investigational Suvecaltamide (JZP385) in Essential Tremor
JAZZ
20 Jun 24
clinical trial (NCT05122650) evaluating the efficacy and safety of suvecaltamide (JZP385), an investigational, highly selective and state-dependent modulator
Actinium Pharmaceuticals (ATNM) Reveals Promising Results from SIERRA Trial at EHA Congress
ATNM
BMRN
EXEL
17 Jun 24
During the congress, Dr. Hannah Choe from Ohio State University, who is also a SIERRA trial investigator, presented compelling data regarding
Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024
JAZZ
1 Jun 24
., M.B.B.S. professor in the Department of Gastrointestinal Medical Oncology and Investigational Cancer Therapeutics
Jazz Pharmaceuticals Showcases Pioneering Research in Sleep Medicine at SLEEP 2024
JAZZ
30 May 24
, Lopez R, Dauvilliers Y. Update on treatment for idiopathic hypersomnia. Expert Opin Investig Drugs. 2018;27
yuzaame955amvpallhsq9r8fiib8 phnvu
JAZZ
29 May 24
Zanidatamab Zanidatamab is an investigational HER2-targeted bispecific antibody that can
w79pwwd994qygypxd5550wn9s6i516m789h
JAZZ
24 Apr 24
at this year's meeting demonstrate our commitment to advancing our portfolio of innovative oncology products and investigational therapies at all stages
10eto72499sytw1ina77c1rd0d4cvnx z8sdtfyua7b
JAZZ
10 Apr 24
.Two posters featuring Jazz's research with investigational suvecaltamide (also known as JZP385) in essential
- Prev
- 1
- Next